Cite
HARVARD Citation
Koren‐Michowitz, M. et al. (n.d.). SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F. British journal of haematology. pp. 811-820. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Koren‐Michowitz, M. et al. (n.d.). SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F. British journal of haematology. pp. 811-820. [Online].